StockWatch
·

AXIS BANK LTD.

BSE: 532215

P/L Snapshot

Q1 FY2027 · standalone

vs Q4 FY2026
Revenue
40.7K
+5.1%
Expenditure
29.1K
+1.1%
Net Profit
7.1K
+0.6%
OPM %
34.31%
+3.71pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0011.4K22.8K34.2K45.6KQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027

Price Chart

Latest News

Quarterly Result18 Jul, 11:30 am

Axis Bank Q1: consolidated PAT ₹7,632 Cr, up 22% YoY as credit costs ease

Axis Bank reported consolidated net profit for the group of ₹7,632 Cr for Q1 FY27, up 22.3% year-on-year, on interest earned (revenue) of ₹35,542 Cr, up 9.9% YoY. Standalone net profit was ₹7,114 Cr (+22.5% YoY), so the two bases tell the same story — no material divergence. Because exceptional items were nil in both the current and year-ago quarters, the reported ~22% is also the underlying figure; no adjustment is needed on the YoY pair. Sequentially profit was essentially flat (+0.3%), but that comparison is misleading: the Q4 FY26 base carried a ₹2,193 Cr one-off tax write-back (Citi-intangibles depreciation allowed) that pushed that quarter's PAT above its own PBT, so QoQ should be read as noise, not a slowdown. The profit growth is a credit-cost story, not a topline one. Consolidated provisions fell 42% YoY to ₹2,337 Cr (from ₹4,034 Cr a year ago), lifting PBT 24% YoY to ₹10,161 Cr and expanding net margin to 17.7% from 15.5%. Operating profit, however, rose just 2.3% YoY to ₹12,499 Cr — operating margin (operating profit/interest earned) compressed to 35.2% from 37.8% as interest expended grew faster than interest earned, a funding-cost/NIM squeeze. So the quarter is margin-expanding at the net line but margin-compressing at the operating line, with lower slippage-driven provisioning doing the work. Against the street, the print is a modest beat: Systematix had previewed PAT of ₹7,452 Cr (+28% YoY) and NII up ~9.4% YoY, with a slight NIM decline on rising deposit costs — the actual ₹7,632 Cr group profit came in above that estimate, and the OPM compression is consistent with the deposit-cost pressure analysts flagged. On guidance, management's last-call marker was a through-cycle NIM of 3.80%, which these results do not disclose directly, so it cannot be verified from the P&L; there is no formal PAT guidance on record and no management press release was extracted with this filing. Concurrent corporate actions: provisional advances were up 18.8% YoY, the bank infused ₹1,499 Cr into Axis Finance and ₹381 Cr into Axis Max Life, and on July 13 Axis Finance ceased to be wholly-owned — diluted 100%→94.92% via a ₹750 Cr Kedaara preferential issue. The ₹2,001 Cr prudent standard-asset provision built in Q4 FY26 was not drawn down this quarter, leaving that buffer intact while headline provisions still fell.

18 Jul 2026, 11:30 am

Corporate Events

Board MeetingAXISBANK
2026
18Jul

Board Meeting

A meeting of the Board of Directors is scheduled to consider…

BSE Filing
Board MeetingAXISBANK
2026
29Jun

Board Meeting

The Board of Directors approved the re-appointment of CH S S…

BSE Filing
Board MeetingAXISBANK
2026
26Jan

Board Meeting

consider and approve the unaudited standalone and consolidat…

BSE Filing
Board MeetingAXISBANK
2025
15Oct

Board Meeting

consider and approve the unaudited standalone and consolidat…

BSE Filing
Board MeetingAXISBANK
2025
17Jul

Board Meeting

To consider and approve the unaudited standalone and consoli…

BSE Filing
Board MeetingAXISBANK
2025
24Apr

Board Meeting

Audited Standalone and Consolidated Financial Results of the…

BSE Filing
Board MeetingAXISBANK
2025
16Jan

Board Meeting

Consider and approve the financial results

BSE Filing
Board MeetingAXISBANK
2024
17Oct

Board Meeting

Consider and approve the unaudited standalone and consolidat…

BSE Filing
Board MeetingAXISBANK
2024
24Jul

Board Meeting

Consider and approve the unaudited standalone and consolidat…

BSE Filing
DividendAXISBANK
2024
30Apr

₹0.84 / share

BSE Filing
Board MeetingAXISBANK
2024
23Jan

Board Meeting

Consider and approve Unaudited Financial Results (Standalone…

BSE Filing